KOD
Price
$3.90
Change
+$0.19 (+5.12%)
Updated
Jul 8 closing price
Capitalization
205.78M
40 days until earnings call
VRDN
Price
$16.04
Change
+$0.15 (+0.94%)
Updated
Jul 8, 04:59 PM (EDT)
Capitalization
1.31B
29 days until earnings call
Interact to see
Advertisement

KOD vs VRDN

Header iconKOD vs VRDN Comparison
Open Charts KOD vs VRDNBanner chart's image
Kodiak Sciences
Price$3.90
Change+$0.19 (+5.12%)
Volume$216.94K
Capitalization205.78M
Viridian Therapeutics
Price$16.04
Change+$0.15 (+0.94%)
Volume$10.09K
Capitalization1.31B
KOD vs VRDN Comparison Chart in %
Loading...
KOD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRDN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KOD vs. VRDN commentary
Jul 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KOD is a StrongBuy and VRDN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 09, 2025
Stock price -- (KOD: $3.90 vs. VRDN: $16.05)
Brand notoriety: KOD and VRDN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KOD: 61% vs. VRDN: 104%
Market capitalization -- KOD: $205.78M vs. VRDN: $1.31B
KOD [@Biotechnology] is valued at $205.78M. VRDN’s [@Biotechnology] market capitalization is $1.31B. The market cap for tickers in the [@Biotechnology] industry ranges from $309.49B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KOD’s FA Score shows that 1 FA rating(s) are green whileVRDN’s FA Score has 0 green FA rating(s).

  • KOD’s FA Score: 1 green, 4 red.
  • VRDN’s FA Score: 0 green, 5 red.
According to our system of comparison, KOD is a better buy in the long-term than VRDN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KOD’s TA Score shows that 4 TA indicator(s) are bullish while VRDN’s TA Score has 4 bullish TA indicator(s).

  • KOD’s TA Score: 4 bullish, 4 bearish.
  • VRDN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both KOD and VRDN are a good buy in the short-term.

Price Growth

KOD (@Biotechnology) experienced а +3.72% price change this week, while VRDN (@Biotechnology) price change was +10.92% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.39%. For the same industry, the average monthly price growth was +14.41%, and the average quarterly price growth was +12.94%.

Reported Earning Dates

KOD is expected to report earnings on Nov 12, 2025.

VRDN is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+9.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VRDN($1.31B) has a higher market cap than KOD($206M). VRDN YTD gains are higher at: -16.275 vs. KOD (-60.804). KOD has higher annual earnings (EBITDA): -162.44M vs. VRDN (-304.76M). VRDN has more cash in the bank: 637M vs. KOD (139M). VRDN has less debt than KOD: VRDN (21.2M) vs KOD (67.6M). VRDN has higher revenues than KOD: VRDN (302K) vs KOD (0).
KODVRDNKOD / VRDN
Capitalization206M1.31B16%
EBITDA-162.44M-304.76M53%
Gain YTD-60.804-16.275374%
P/E RatioN/AN/A-
Revenue0302K-
Total Cash139M637M22%
Total Debt67.6M21.2M319%
FUNDAMENTALS RATINGS
KOD vs VRDN: Fundamental Ratings
KOD
VRDN
OUTLOOK RATING
1..100
1971
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
91
Overvalued
PROFIT vs RISK RATING
1..100
10089
SMR RATING
1..100
9897
PRICE GROWTH RATING
1..100
4748
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KOD's Valuation (27) in the Biotechnology industry is somewhat better than the same rating for VRDN (91). This means that KOD’s stock grew somewhat faster than VRDN’s over the last 12 months.

VRDN's Profit vs Risk Rating (89) in the Biotechnology industry is in the same range as KOD (100). This means that VRDN’s stock grew similarly to KOD’s over the last 12 months.

VRDN's SMR Rating (97) in the Biotechnology industry is in the same range as KOD (98). This means that VRDN’s stock grew similarly to KOD’s over the last 12 months.

KOD's Price Growth Rating (47) in the Biotechnology industry is in the same range as VRDN (48). This means that KOD’s stock grew similarly to VRDN’s over the last 12 months.

KOD's P/E Growth Rating (100) in the Biotechnology industry is in the same range as VRDN (100). This means that KOD’s stock grew similarly to VRDN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KODVRDN
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 2 days ago
73%
MACD
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 6 days ago
85%
Bullish Trend 2 days ago
79%
Declines
ODDS (%)
Bearish Trend 21 days ago
89%
Bearish Trend 9 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 2 days ago
87%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
KOD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRDN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYKCX82.30N/A
N/A
Rydex Banking C
CSRSX67.60N/A
N/A
Cohen & Steers Realty Shares L
FRMCX24.67N/A
N/A
Franklin Mutual Small-Mid Cap Val A
AFNIX25.77N/A
N/A
Bahl & Gaynor Income Growth I
QMORX23.41-0.10
-0.43%
AQR Large Cap Momentum Style R6

VRDN and

Correlation & Price change

A.I.dvisor indicates that over the last year, VRDN has been loosely correlated with AURA. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if VRDN jumps, then AURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRDN
1D Price
Change %
VRDN100%
+1.01%
AURA - VRDN
50%
Loosely correlated
+1.46%
DNLI - VRDN
49%
Loosely correlated
+0.56%
DSGN - VRDN
48%
Loosely correlated
+2.82%
BEAM - VRDN
48%
Loosely correlated
+5.84%
TERN - VRDN
47%
Loosely correlated
+13.25%
More